The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus

Daniel M. Huse, Gerry Oster, Alice R. Killen, Michael J. Lacey, Graham A. Colditz

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Abstract

Persons with diabetes experience elevated risks of a variety of other illnesses— including circulatory, visual, neurological, renal, and skin disorders—relative to their nondiabetic peers. Previous estimates of the economic burden of diabetes, however, have not taken full account of this related morbidity and mortality and have therefore understated the cost to the nation due to this disease. Accordingly, we estimated the economic costs of type II, or non-insulin-dependent, diabetes mellitus, reflecting its contribution to the total burden of disease in the United States. In 1986, non—insulin-dependent diabetes mellitus was responsible for $11.6 billion in health care expenditures, including $6.8 billion for diabetic care and $4.8 billion attributable to an excess prevalence of related (principally cardiovascular) conditions. The human toll of non—insulin-dependent diabetes mellitus included 144 000 deaths—about 6.8% of total US mortality—and the total disability of 951 000 persons. The total economic burden of non—insulin-dependent diabetes mellitus in 1986, including health care expenditures and productivity forgone due to disability and premature mortality, was $19.8 billion.

Original languageEnglish
Pages (from-to)2708-2713
Number of pages6
JournalJAMA: The Journal of the American Medical Association
Volume262
Issue number19
DOIs
StatePublished - Nov 17 1989

Fingerprint

Dive into the research topics of 'The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this